[{"Assets_0_FY_USD":10983400000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":593000000.0,"NetIncomeLoss_4_FY_USD":131000000.0,"NetIncomeLoss_1_FY_USD":81500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":135900000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":137800000.0,"StockholdersEquity_0_FY_USD":5668000000.0,"EarningsPerShareBasic_4_FY_USD":0.95,"EarningsPerShareBasic_1_FY_USD":0.6,"Ticker":"PRGO","CIK":"1585364","name":"PERRIGO CO PLC","OfficialName":"Perrigo Company plc Ordinary Shares","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4754722726.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20190227"}]